Form 8-K - Current report:
SEC Accession No. 0001193125-25-276249
Filing Date
2025-11-12
Accepted
2025-11-12 09:25:41
Documents
10
Period of Report
2025-11-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K lctx-20251112.htm   iXBRL 8-K 40252
  Complete submission text file 0001193125-25-276249.txt   141288

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lctx-20251112.xsd EX-101.SCH 23883
12 EXTRACTED XBRL INSTANCE DOCUMENT lctx-20251112_htm.xml XML 4516
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 251469753
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)